Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

HotSpot Therapeutics discovers allosteric medicines that modulate natural regulatory hotspots on proteins to treat cancer, autoimmune and other diseases. The company uses its proprietary Smart…

HotSpot Therapeutics discovers allosteric medicines that modulate natural regulatory hotspots on proteins to treat cancer, autoimmune and other diseases. The company uses its proprietary Smart…
Founded: 2017
Headquarters: Boston, Massachusetts
Focus: Allosteric small-molecule therapies for cancer and autoimmune disease
Proprietary platform: Smart Allostery / SpotFinder
Clinical asset: HST-1011 (oral allosteric CBL-B inhibitor) in clinical development
Total funding (reported): USD 210,000,000
Drug discovery and development for oncology and immunology using allosteric modulation of proteins.
2017
Biotechnology Research
USD 45,000,000
USD 65,000,000
USD 100,000,000
“Atlas Venture; Sofinnova Partners; S.R. One; Pivotal bioVenture Partners; Tekla Capital Management; MRL Ventures Fund; Solasta Ventures; Brace Pharma; LSP; B Capital; Monashee; CaaS Capital Management; Revelation Partners”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week
| Company |
|---|